| AMF | Alternating magnetic field |
| AP | Activator protein |
| APC | Antigen presenting cells |
| APTES | 3-Aminopropyltriethoxysilane |
| 10B1 | Boron-10 |
| 10B1-BPA | 10B1-para-Boronophenylalanine hydrochloride |
| BNCTT | Boron neutron capture thermal therapy |
| BRAFi | Braf inhibitor |
| CAP | Cysteaminylphenol |
| CP | Cysteinylphenol |
| CTI therapy | Chemo-thermo-immunotherapy |
| CTL | Cytotoxic T lymphocytes |
| CTLA-4 | Cytotoxic T lymphocyte-associated 4 |
| DCs | Dendric cells |
| Dopeba | 3,4-dihydroxyphenethylboric acid |
| DDS | Drug delivery system |
| GSH | Glutathione |
| HSPs | Heat shock proteins |
| ICI | Immune checkpoint inhibitor |
| ip | Intraperitoneal injection |
| irAE | Immune-related adverse events |
| iv | intravenous infusion |
| M | Magnetite nanoparticle |
| MCL | Magnetite cationic liposome |
| MEKi | MEK inhibitor |
| NAcCAP | N-Acetyl-4SCAP |
| NPrCAP | N-Propionyl-4-S-CAP |
| NPrCAQ | N-Propionyl-4-S-cysteaminyl-1,2-benzoquinone |
| OS | Overall survival |
| PD-1 | Programmed cell death-1 |
| PEG | Polyethylene glycol |
| RFS | Recurrence-free survival |
| ROS | Reactive oxygen species |
| 4SCAC | 4-S-Cysteaminylcatechol |
| 4SCAP | 4-S-Cysteaminylphenol |
| 5SCD | 5-S-Cysteinyldopa |
| 4SCP | 4-S-Cysteinylphenol |
| TGN | Trans-Golgi network |
| TLR | Toll-like receptors |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.